Novel sEH inhibitors and their use

Details for Australian Patent Application No. 2008310732 (hide)

Owner GlaxoSmithKline LLC

Inventors Thalji, Reema K.; Marino Jr., Joseph Paul; Ding, Yun

Agent Davies Collison Cave

Pub. Number AU-B-2008310732

PCT Pub. Number WO2009/049157

Priority 60/979,154 11.10.07 US

Filing date 10 October 2008

Wipo publication date 16 April 2009

Acceptance publication date 8 March 2012

International Classifications

A01N 43/66 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/049157 Priority application(s): WO2009/049157

8 March 2012 Application Accepted

  Published as AU-B-2008310732

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008310734-Delivering osmolytes by nasal cannula

2008310730-Storing location information to locate a femto cell at a user equipment database